Biochimica et Biophysica Acta-Reviews on Cancer

Papers
(The TQCC of Biochimica et Biophysica Acta-Reviews on Cancer is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Tumour cell-induced platelet aggregation in breast cancer: Scope of metal nanoparticles389
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective263
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids197
Nutrition and dietary restrictions in cancer prevention195
miRNAs and androgen deprivation therapy for prostate cancer165
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance155
Uveal melanoma modeling in mice and zebrafish129
The interaction of SET and protein phosphatase 2A as target for cancer therapy109
Reflections on drug resistance to KRAS inhibitors and gene silencing/editing tools for targeting mutant KRAS in cancer treatment106
VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis103
Advances in epigenetic modifications and cervical cancer research100
Progress and challenges of immunotherapy in triple-negative breast cancer95
ESR1 activating mutations: From structure to clinical application91
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?82
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications80
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies79
Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications77
Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells73
Advances and prospects of mRNA vaccines in cancer immunotherapy71
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer69
Biomarkers in high grade serous ovarian cancer67
Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights65
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature63
Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications63
Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects57
CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting54
Targeting lipid metabolism in cancer metastasis53
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting50
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges50
S100A8 and S100A9 in Cancer48
In what area of biology has a “new” type of cell death been discovered?48
Long non-coding RNAs: A view to kill ovarian cancer47
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects47
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors47
Recent insights into RNA m5C methylation modification in hepatocellular carcinoma46
Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma46
Targeting Cdc20 for cancer therapy45
Multifaceted roles of neutrophils in tumor microenvironment45
The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches45
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions45
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential44
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy44
Editorial Board43
Nondiploid cancer cells: Stress, tolerance and therapeutic inspirations43
Matrisomics: Beyond the extracellular matrix for unveiling tumor microenvironment43
Intestinal multicellular organoids to study colorectal cancer42
Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer42
Antibody-drug conjugates in breast cancer: Marching from HER2-overexpression into HER2-low42
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma41
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights41
Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all41
Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies40
Predictive and prognostic value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors: A systematic review and meta-analysis40
An overview of BAP1 biological functions and current therapeutics40
Focus on mast cells in the tumor microenvironment: Current knowledge and future directions39
A role for RIO kinases in the crosshair of cancer research and therapy39
Implications of viral infection in cancer development39
Epithelial-Mesenchymal Transition in Cancer: A Focus on Itraconazole, a Hedgehog Inhibitor39
Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment38
Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment38
CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy38
Refinement of safety and efficacy of anti-cancer chemotherapeutics by tailoring their site-specific intracellular bioavailability through transporter modulation37
Platinum-based systematic therapy in triple-negative breast cancer37
Vagus innervation in the gastrointestinal tumor: Current understanding and challenges37
Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression37
Current advances in comprehensive omics data mining for oncology and cancer research37
Antibody-drug conjugates in HER-2 negative breast cancers with poor prognosis35
Combination therapy in cancer: The potential of tetrandrine as a polytherapy for acute myeloid leukemia35
The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer35
In vitro anticancer properties of anthocyanins: A systematic review35
Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy35
ASPORIN: A root of the matter in tumors and their host environment34
Advances in clinical immunotherapy for gastric cancer33
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview32
HOXA1, a breast cancer oncogene32
Overview of splicing variation in ovarian cancer32
Emerging strategies to overcome PARP inhibitors' resistance in ovarian cancer31
The microbiota-m6A-metabolism axis: Implications for therapeutic strategies in gastrointestinal cancers31
Schwann cells and enteric glial cells: Emerging stars in colorectal cancer31
Colorectal cancer: Metabolic interactions reshape the tumor microenvironment31
Research progress on the regulatory role of lactate and lactylation in tumor microenvironment31
Dual role of Snail1 as transcriptional repressor and activator31
Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages31
Exosomal non-coding RNAs (ncRNAs) as potential biomarkers in tumor early diagnosis30
Strategies for studying immune and non-immune human and canine mammary gland cancer tumour infiltrate30
Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors30
Exploring the gut microbiome: A potential biomarker for cancer diagnosis, prognosis, and therapy30
New target DDR1: A “double-edged sword” in solid tumors29
RUNX1 and cancer29
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer29
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors29
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma29
USP7 - a crucial regulator of cancer hallmarks28
Potentially diagnostic and prognostic roles of piRNAs/PIWIs in pancreatic cancer: A review28
Data-driven approaches to advance research and clinical care for pediatric cancer28
Stress granules dynamics and promising functions in pancreatic cancer28
A novel approach to reducing disparities in health outcomes by enhancing interpretation of cancer clinical trials for underrepresented patient groups28
Interleukin-1 signaling in solid organ malignancies28
Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers27
Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor27
Consequence of distinctive expression of MUC2 in colorectal cancers: How much is actually bad?27
Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance27
Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers27
New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas27
Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application27
To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H326
Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment26
Keratin 1 as a cell-surface receptor in cancer26
Role of F-box proteins in human upper gastrointestinal tumors26
From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models26
SNARE proteins: Core engines of membrane fusion in cancer26
Epigenetic regulation of cancer-associated fibroblast heterogeneity26
A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer25
Dual roles of human endogenous retroviruses in cancer progression and antitumor immune response25
The clinical significance and correlative signaling pathways of paired box gene 9 in development and carcinogenesis25
A digital highway for data fluidity and data equity in precision medicine25
Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy24
Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors24
Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p5324
The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics24
Epidermal growth factor receptor PROTACs as an effective strategy for cancer therapy: A review24
Research progress of mitochondria and cytoskeleton crosstalk in tumour development23
Tumoral heterogeneity in neuroblastoma23
Expression and function of NF-Y subunits in cancer23
Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine23
The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy23
Radiotherapy modulates autophagy to reshape the tumor immune microenvironment to enhance anti-tumor immunity in esophageal cancer23
Histone deacetylase complexes: Structure, regulation and function23
Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents23
Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications23
Improving DCIS diagnosis and predictive outcome by applying artificial intelligence22
Role of the intratumoral microbiome in tumor progression and therapeutics implications22
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways22
βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies22
Editorial Board22
The interplay between microbiome and host factors in pathogenesis and therapy of head and neck cancer22
Centrosome amplification in cancer and cancer-associated human diseases22
Psychological intervention to treat distress: An emerging frontier in cancer prevention and therapy22
Finding the junction between claudins and endometrial carcinoma22
Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance22
Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors22
Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives22
B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer22
Tumor microenvironment diversity and plasticity in cancer multidrug resistance21
Advances in tuft cells, a chemosensory cell in sequential diseases of the pancreas21
The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors21
Biological function, regulatory mechanism, and clinical application of mannose in cancer21
The signaling pathways regulated by KRAB zinc-finger proteins in cancer21
Enhancing immune checkpoint blockade therapy of genitourinary malignancies by co-targeting PMN-MDSCs21
Cancer-associated fungi: An emerging powerful player in cancer immunotherapy21
Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes21
Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer21
Editorial Board21
Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm21
Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?21
Decoding the role of intratumoral microbiota in gastric cancer20
The potential of TRP channels as new prognostic and therapeutic targets against prostate cancer progression20
Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer20
Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer20
Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology20
TERT promoter mutations in gliomas: Molecular roles in tumorigenesis, metastasis, diagnosis, prognosis, therapeutic targeting, and drug resistance20
The role of TRIM25 in the occurrence and development of cancers and inflammatory diseases20
The role of exosomes in the tumour microenvironment on macrophage polarisation20
Roles of K(H)SRP in modulating gene transcription throughout cancer progression: Insights from cellular studies to clinical perspectives20
GSDM family and glioma19
Cyclin-dependent kinases in DNA damage response19
Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy19
Thymic epithelial tumor medical treatment: A narrative review19
Odors and cancer: Current status and future directions19
A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment19
Comprehensive insights of etiological drivers of hepatocellular carcinoma: Fostering targeted nano delivery to anti-cancer regimes19
Protein induced by vitamin K absence or antagonist II: Experience to date and future directions19
Molecular and immune pathobiology of human angiosarcoma19
0.047425985336304